News & Trends - Pharmaceuticals

First immunotherapy treatment PBS listed in small cell lung cancer

Health Industry Hub | February 19, 2020 |
[Total: 1    Average: 5/5]

Pharma News: Effective 1 March 2020 the first immunotherapy treatment for small cell lung cancer (SCLC) will be available on the Pharmaceutical Benefits Scheme (PBS).

Federal Health Minister, The Hon. Greg Hunt MP, today announced the reimbursement of Roche’s TECENTRIQ (atezolizumab) – an immunotherapy that works with the body’s own immune system to fight cancer – in combination with chemotherapy (etoposide and carboplatin), for the treatment of patients with previously untreated extensive stage small cell lung cancer (ES-SCLC). TECENTRIQ was TGA registered in August 2019.

The announcement is coinciding with the 8th Biennial Australian Lung Cancer Conference (ALCC) in Melbourne.

SCLC accounts for up to 15% of all lung cancers, with an estimated 2,000 Australians expected to be diagnosed with the disease in 2020. Most patients diagnosed with SCLC survive less than one year from diagnosis.

Enhance corporate branding and boost thought leadership to attract and retain quality employees. How does your company culture measure up in the industry, according to results from employee feedback? Get the benchmark analysis by contacting us.

According to medical oncologist, Dr Steven Kao, Chris O’Brien Lifehouse, Sydney “Survival rates for SCLC are unacceptably low. This is partly due to the aggressive, fast-growing nature of the disease, and to the few recent advances in the management of SCLC.

“For those diagnosed with ES-SCLC, chemotherapy has been the standard treatment option for many decades. Reimbursement of ES-SCLC treatments is an important step forward, potentially in both prolonging, and improving the quality of life for all Australians diagnosed with this devastating disease.”

Happily married truck driver, father-to-two and grandfather-to-one, Glen, 58, Sydney received a heart-breaking diagnosis of ES-SCLC, and was informed he had less than 12 months to live.

“I had two lumps on my neck that I thought were just cysts. I assumed they were harmless, so delayed getting them checked out. When I finally visited the doctor and went through eight difficult weeks of tests, I was eventually diagnosed with ES-SCLC, and told I had less than 12 months to live.

“Given I’m a husband, a dad, and a grandpa, this news was absolutely devastating for all of us. I wanted to be here to see my grandson grow up,” said Glen.

According to Lung Foundation Australia CEO, Mark Brooke, Brisbane, the availability of an immunotherapy for ES-SCLC will be welcome news to the Australian lung cancer community.

“After being told it was unlikely I would live to see the following year, I’ve since returned to work, am back in my shed with my motorbikes and hot rods, and have just celebrated my grandson’s fourth birthday,” Glen said.

Register FREE to receive the latest industry news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech news - New 5 minute coronavirus test delivers clear results on infection

New 5 minute coronavirus test delivers clear results on infection

Health Industry Hub | April 9, 2020 |

A new type of sensor device from the German health technology company Digital Diagnostics AG can be used for immediate […]


Marketing & Strategy

Marketing & Strategy in Healthcare - Customer-Centric Engagement During COVID-19

Customer-Centric Engagement During COVID-19

Health Industry Hub | April 8, 2020 |

Navigating the multichannel maze in COVID 19 times to engage healthcare professionals (HCPs) and patients has been challenging for most […]


News & Trends - Medical Technology

MedTech News - Stryker launches limited-release medical bed to support critical needs during COVID-19 pandemic

Stryker launches limited-release medical bed to support critical needs during COVID-19 pandemic

Health Industry Hub | April 8, 2020 |

MedTech News: Stryker has developed a low-cost, limited-release emergency response bed to quickly aid healthcare providers with efficient care during […]



Medical News - AMA urges Australians to continue with ongoing medical care amid COVID-19 crisis

AMA urges Australians to continue with ongoing medical care amid COVID-19 crisis

Health Industry Hub | April 8, 2020 |

Medical News: The AMA is urging people to keep a close watch on their ongoing health care and maintenance, and […]